These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31095696)
1. HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances. Mardal M; Andreasen MF; Mollerup CB; Stockham P; Telving R; Thomaidis NS; Diamanti KS; Linnet K; Dalsgaard PW J Anal Toxicol; 2019 Aug; 43(7):520-527. PubMed ID: 31095696 [TBL] [Abstract][Full Text] [Related]
2. How to perform spectrum-based LC-HR-MS screening for more than 1,000 NPS with HighResNPS consensus fragment ions. Davidsen A; Mardal M; Linnet K; Dalsgaard PW PLoS One; 2020; 15(11):e0242224. PubMed ID: 33180844 [TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances". Mardal M; Andreasen MF; Mollerup CB; Stockham P; Telving R; Thomaidis NS; Diamanti KS; Linnet K; Dalsgaard PW J Anal Toxicol; 2019 Jul; 43(6):e7-e8. PubMed ID: 31241748 [No Abstract] [Full Text] [Related]
5. Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021. Gundersen POM; Pasin D; Slørdal L; Spigset O; Josefsson M Forensic Sci Int; 2024 Aug; 361():112131. PubMed ID: 38981414 [TBL] [Abstract][Full Text] [Related]
6. Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition. Mollerup CB; Dalsgaard PW; Mardal M; Linnet K Drug Test Anal; 2017 Jul; 9(7):1052-1061. PubMed ID: 27750404 [TBL] [Abstract][Full Text] [Related]
7. Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018. Gundersen POM; Broecker S; Slørdal L; Spigset O; Josefsson M Forensic Sci Int; 2020 Jun; 311():110274. PubMed ID: 32302877 [TBL] [Abstract][Full Text] [Related]
8. Target and suspect screening of (new) psychoactive substances in South Korean wastewater by LC-HRMS. Lee HJ; Oh JE Sci Total Environ; 2023 Jun; 875():162613. PubMed ID: 36871726 [TBL] [Abstract][Full Text] [Related]
9. A method for the sensitive targeted screening of synthetic cannabinoids and opioids in whole blood by LC-QTOF-MS with simultaneous suspect screening using HighResNPS.com. Trobbiani S; Stockham P; Kostakis C J Anal Toxicol; 2023 Dec; 47(9):807-817. PubMed ID: 37632762 [TBL] [Abstract][Full Text] [Related]
10. Identification of New Psychoactive Substances in Seized material Using UHPLC-QTOF-MS and An Online Mass Spectral Database. von Cüpper M; Dalsgaard PW; Linnet K J Anal Toxicol; 2021 Jan; 44(9):1047-1051. PubMed ID: 32232329 [TBL] [Abstract][Full Text] [Related]
11. Identification of Emerging Novel Psychoactive Substances by Retrospective Analysis of Population-Scale Mass Spectrometry Data Sets. Skinnider MA; Mérette SAM; Pasin D; Rogalski J; Foster LJ; Scheuermeyer F; Shapiro AM Anal Chem; 2023 Nov; 95(47):17300-17310. PubMed ID: 37966487 [TBL] [Abstract][Full Text] [Related]
12. Identification of clobromazolam in Australian emergency department intoxications using data-independent high-resolution mass spectrometry and the HighResNPS.com database. Castle JW; Syrjanen R; Di Rago M; Schumann JL; Greene SL; Glowacki LL; Gerostamoulos D J Anal Toxicol; 2024 Jun; 48(5):273-280. PubMed ID: 38459915 [TBL] [Abstract][Full Text] [Related]
13. Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS. da Cunha KF; Oliveira KD; Huestis MA; Costa JL J Anal Toxicol; 2020 Oct; 44(7):697-707. PubMed ID: 32685960 [TBL] [Abstract][Full Text] [Related]
14. A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples. Kinyua J; Negreira N; Ibáñez M; Bijlsma L; Hernández F; Covaci A; van Nuijs AL Anal Bioanal Chem; 2015 Nov; 407(29):8773-85. PubMed ID: 26396082 [TBL] [Abstract][Full Text] [Related]
15. Development of a single retention time prediction model integrating multiple liquid chromatography systems: Application to new psychoactive substances. Pasin D; Mollerup CB; Rasmussen BS; Linnet K; Dalsgaard PW Anal Chim Acta; 2021 Nov; 1184():339035. PubMed ID: 34625246 [TBL] [Abstract][Full Text] [Related]
16. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997 [TBL] [Abstract][Full Text] [Related]
17. Technical and health governance aspects of the external quality assessment system for classical and new psychoactive substances analysis testing in blood. Di Gaudio F; Giaccone V; Cucina A; Indelicato S; Raso M; Brunacci G; Lundari A; Rotolo MC; Busardò F; La Rocca M J Pharm Biomed Anal; 2024 Aug; 245():116175. PubMed ID: 38728951 [TBL] [Abstract][Full Text] [Related]
18. Target and suspect screening of psychoactive substances in sewage-based samples by UHPLC-QTOF. Baz-Lomba JA; Reid MJ; Thomas KV Anal Chim Acta; 2016 Mar; 914():81-90. PubMed ID: 26965330 [TBL] [Abstract][Full Text] [Related]
19. Wide-scope target and suspect screening methodologies to investigate the occurrence of new psychoactive substances in influent wastewater from Athens. Diamanti K; Aalizadeh R; Alygizakis N; Galani A; Mardal M; Thomaidis NS Sci Total Environ; 2019 Oct; 685():1058-1065. PubMed ID: 31390696 [TBL] [Abstract][Full Text] [Related]
20. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis. Vandergrift GW; Gill CG J Mass Spectrom; 2019 Sep; 54(9):729-737. PubMed ID: 31432563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]